GTG — Genetic Technologies Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro Cap

Annual balance sheet for Genetic Technologies, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.

	C2020 June 30th	2021 June 30th	2022 June 30th	2023 June 30th	2024 June 30th
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Short Term Investments	14.2	20.9	11.7	7.85	1.02
Net Total Accounts Receivable
Net Total Receivables	0.789	1.07	2.42	1.92	2.13
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	15.2	22.2	14.7	10.5	3.7
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	0.44	0.638	0.953	0.599	0.264
Net Goodwill
Net Intangible Assets
Other Long Term Assets
Total Assets	15.6	23	20.8	14.9	6.19
Accounts Payable
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	1.4	1.41	3.81	3.31	4.2
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Liabilities	1.64	1.44	4.37	3.69	4.36
Common Stock
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	14	21.5	16.4	11.2	1.83
Total Liabilities & Shareholders' Equity	15.6	23	20.8	14.9	6.19
Total Common Shares Outstanding